<DOC>
	<DOCNO>NCT00262028</DOCNO>
	<brief_summary>The purpose study evaluate safety immunogenicity Novartis ( formerly Chiron ) Meningococcal ACWY Conjugate Vaccine administer healthy child age 1 - 10 year</brief_summary>
	<brief_title>Study Safety Immune Response Meningococcal Vaccine Administered Healthy Children</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Group 1 : Healthy child 210 year age ; Group 2 : Healthy toddler 1223 month age ; date age appropriate immunization diphtheria , tetanus , pertussis , polio , hepatitis B , Hemophilus influenzae type b , pneumococcus . Group 1 : Subjects previous suspect disease cause N. meningitidis ; previous immunization meningococcal vaccine vaccine contain meningococcal antigen ( ) ; Any serious acute , chronic progressive disease . Group 2 : Subjects previous suspect disease cause N. meningitidis previous immunization meningococcal vaccine vaccine contain meningococcal antigen ( ) ; Any serious acute , chronic progressive disease .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>